Loading...
In keeping with our holiday tradition of highlighting the year's top stories from Journal Watch Gastroenterology, I have selected 10 stories that I believe will be of keen interest to all gastroenterologists. Here's a brief overview.
In the esophageal disease arena, we now know that endoscopic ablative therapies have become the standard of care in managing dysplastic Barrett esophagus, but incident cancers and recurrent dysplasia are being seen after successful complete ablation. Thus, continued surveillance of these patients is required. As for eosinophilic esophagitis, we can now add food elimination diets (e.g., dairy, wheat) to our therapeutic armamentarium.
With regard to colonic disease, we now have proof that we can prevent both distal…